Organization
Pfizer Ltd, Inflammation and Immunology, Tadworth, United Kingdom
1 abstract
Abstract
ASSOCIATION BETWEEN BASELINE CARDIOVASCULAR RISK AND INCIDENCE RATES OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND MALIGNANCIES IN PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS RECEIVING TOFACITINIBOrg: Central Connecticut Dermatology Research, Cromwell, CT, United States of America, Charité Universitätsmedizin, Department of Rheumatology, Infectious Diseases and Rheumatology, Berlin, Germany, German Rheumatism Research Center Berlin, Epidemiology, Berlin, Germany, Pfizer Inc, Inflammation and Immunology, Groton, CT, United States of America, Pfizer Inc, Inflammation and Immunology, New York, NY, United States of America,